Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer

K. R. Schoennemann, Lene Weber Vestermark, H. Jensen, Jon Kroll Bjerregaard, M. Krogh, C. Qvortrup, L. Tarpgaard, M. W. Ejlsmark, P. Pfeiffer

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number2309
JournalEuropean Journal of Cancer
Volume51
Issue numberS3
Pages (from-to)S435
Number of pages1
ISSN0959-8049
DOIs
Publication statusPublished - 2015
EventEuropean Cancer Congress (ECC) 2015 - Wien, Austria
Duration: 25. Sep 201529. Sep 2015

Conference

ConferenceEuropean Cancer Congress (ECC) 2015
Country/TerritoryAustria
CityWien
Period25/09/201529/09/2015

Cite this